Avista 10-Q: $49M Q3 Net Income, $100M Short-Term Loan Planned on Delayed Regulatory Recovery
AVA is trading near its 52-week low of $34.46 (11% above the low) on elevated volume (1.8× avg).
Summary
Avista's Q3 net income rose to $49 million ($0.57 per diluted share) from $29 million, but most of the gain was non-utility investment appreciation that is already reversing. The 10-Q also discloses a planned short-term loan of up to $100 million by year-end due to delayed regulatory recovery, plus up to $110 million of 2027 equity issuance.
Key Events · Earnings and Guidance · AVA
-
Q3 EPS $0.57, But Utility Only $0.38
Q3 2026 GAAP net income was $49 million, or $0.57 per diluted share, versus $29 million and $0.36 a year ago. Non-GAAP utility earnings were $33 million, or $0.38 per diluted share, versus $30 million and $0.37.
-
Equity Method Gain Is Reversing
Q3 equity method earnings of $23 million came mostly from ERock, Inc.'s June 2026 IPO. Avista estimates a $7 million fair-value decrease to be recognized in Q4 2026 and a $3 million loss based on November 3, 2026 fair value.
-
Up to $100M Short-Term Loan Planned
Due to increased regulatory deferrals and delayed recovery, Avista plans to obtain a short-term loan of up to $100 million by the end of Q4 2026, with $168 million of available liquidity under the Avista Corp. committed line of credit as of September 30, 2026.
-
2027 Equity Issuance of Up to $110M
Avista issued $58 million of common stock in the first nine months of 2026, including 1.4 million shares at-the-market, and expects up to $15 million more in 2026 plus up to $110 million of common stock and approximately $220 million of long-term debt in 2027.
Analysis · AVA · Energy & Transportation
The headline $0.57 EPS was already out via the 8-K, but the full 10-Q shows how little of it is utility earnings: $33 million of the $49 million came from the regulated utility, while $23 million of equity method earnings came from an ERISA-style fund stake whose value jumped on ERock's IPO. That gain is already reversing — Avista expects a $7 million hit in Q4 and estimates a $3 million loss based on November 3 fair value — so Q4 earnings will look much weaker than Q3. More important for the balance sheet: the company now says it will borrow up to $100 million short-term by year-end because regulatory deferrals (decoupling surcharges, ERM costs) are piling up and recovery is slow, on top of $331 million already drawn on the revolver. It also plans up to $110 million of equity in 2027, which is real dilution coming after $58 million raised in the first nine months of 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AVA was trading at $38.11 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $34.46 to $43.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.